Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 19/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8214008 | 1.00 | IRAK4 (0.34) | IRAK4 | |
| SCHEMBL14724552 | 1.00 | IRAK4 (0.34) | IRAK4 | |
| SCHEMBL10109671 | 0.93 | IRAK4 (0.32) | IRAK4 | |
| SCHEMBL19723229 | 0.84 | — | — | |
| SCHEMBL17488360 | 0.84 | — | — | |
| SCHEMBL17488359 | 0.84 | — | — | |
| SCHEMBL530404 | 0.78 | KDM1A (0.38) | — | |
| SCHEMBL665282 | 0.78 | KDM1A (0.38) | — | |
| SCHEMBL17458 | 0.78 | — | — | |
| SCHEMBL11525280 | 0.78 | KDM1A (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161906-A1 | METHOD FOR REMOVING GASES | EVONIK OPERATIONS GMBH (DE) | 2025-05-22 | — | — | US | disclosed |
| EP-4556101-A1 | GAS REMOVAL METHOD | Evonik Operations GmbH (DE) | 2025-05-21 | — | — | EP | disclosed |
| US-20250034165-A1 | COMPOUND CONTAINING CYCLOALKYL OR HALOALKYL | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2025-01-30 | — | — | US | disclosed |
| EP-4442690-A1 | COMPOUND CONTAINING CYCLOALKYL OR HALOALKYL | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2024-10-09 | — | — | EP | disclosed |
| EP-3640248-B1 | AMINOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF | BEIJING ADAMADLE BIOTECHNOLOGY LLC (CN) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023098730-A1 | COMPOUND CONTAINING CYCLOALKYL OR HALOALKYL | 正大天晴药业集团股份有限公司 | 2023-06-08 | — | — | WO | disclosed |
| WO-2023016434-A1 | COMPOUNDS TARGETING MUTANT OF P53 | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2023-02-16 | — | — | WO | disclosed |
| US-11352352-B2 | Aminopyrimidine compound, preparation method therefor and use thereof | Beijing Adamadle Biotechnology Limited Liability Company (CN) | 2022-06-07 | — | — | US | disclosed |
| US-11180474-B2 | Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-11-23 | — | — | US | disclosed |
| EP-3490983-B1 | DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-02-17 | — | — | EP | disclosed |
| US-7626021-B2 | Fused ring heterocycle kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-7626021-B2 | Fused ring heterocycle kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-20070287711-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| US-20070287711-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| EP-1016694-B1 | Pigment dispersants, pigment dispersions and writing or recording pigment inks | DAINICHISEIKA COLOR CHEM (JP) | 2005-01-12 | — | — | EP | disclosed |
| EP-1024179-B1 | Pigment dispersions for color filters, fabrication process of color filters, and color filters | DAINICHISEIKA COLOR & AMP CHEM (JP) | 2003-12-17 | — | — | EP | disclosed |
| US-6302953-B1 | TRIAZINE-SUBSTITUTED ANTHRAQUINONE DISPERSANTS | DAINICHISEIKA COLOR CHEMICALS MFG. CO., LTD. (JP) | 2001-10-16 | — | — | US | disclosed |
| US-6299676-B1 | DISPERSANT FOR ORGANIC PIGMENTS, FORMING PIGMENT DISPERSIONS HAVING EXCELLENT FLUIDITY, DISPERSION STABILITY, STORAGE STABILITY | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 2001-10-09 | — | — | US | disclosed |
| EP-1024179-A1 | Pigment dispersions for color filters, fabrication process of color filters, and color filters | DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) | 2000-08-02 | — | — | EP | disclosed |
| EP-1016694-A2 | Pigment dispersants, pigment dispersions and writing or recording pigment inks | DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) | 2000-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287711-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | MAP3K20, TTK, MAP3K19 | IRAK4 424/4885 |
| US-11180474-B2 | Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors | TLR9, TLR7, TLR8 | IRAK4 15/4885 |
| US-11352352-B2 | Aminopyrimidine compound, preparation method therefor and use thereof | WEE1, WEE2, EGFR | IRAK4 952/4885 |
| US-20250034165-A1 | COMPOUND CONTAINING CYCLOALKYL OR HALOALKYL | KRAS, HRAS, VHL | IRAK4 4837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.